Trinity Biotech (TRIB) Change in Working Capital (2009 - 2024)

Trinity Biotech has disclosed Change in Working Capital across 14 years of filings, most recently posting $7.0 million for Q4 2024.

• Change in Working Capital for Q4 2024 came in at $7.0 million, up 169.41% year-over-year; the trailing twelve-month figure through Dec 2024 was $12.5 million (up 145.63% YoY), and the FY2025 annual result was -$186000.0, changed N/A from the prior year.
• Change in Working Capital came in at $7.0 million for Q4 2024 at Trinity Biotech, up from $2.6 million in the prior quarter.
• In the past five years, Change in Working Capital ranged from a high of $10.2 million in Q4 2020 to a low of -$2.6 million in Q3 2020.
• The 5-year median for Change in Working Capital is $995.0 (2022), against an average of $1.6 million.
• Peak annual rise in Change in Working Capital reached 3266.36% in 2020, while the deepest fall reached 256.41% in 2020.
• Trinity Biotech's Change in Working Capital stood at $10.2 million in 2020, then plunged by 51.76% to $4.9 million in 2021, then sank by 37.57% to $3.1 million in 2022, then decreased by 15.0% to $2.6 million in 2023, then jumped by 169.41% to $7.0 million in 2024.
• The last three Change in Working Capital figures came in at $7.0 million (Q4 2024), $2.6 million (Q4 2023), and -$178000.0 (Q3 2023), per Business Quant data.